Highlights and Quick Summary
Current EV/EBITDA of Organigram Holdings Inc. is 0.0 (as of August 31, 2022)
- EV/EBITDA for the quarter ending February 28, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly EV/EBITDA decreased by NaN%
- Annual EV/EBITDA for 2022 was 0.0 (a NaN% decrease from previous year)
- Annual EV/EBITDA for 2021 was 0.0 (a NaN% decrease from previous year)
- Annual EV/EBITDA for 2020 was 0.0 (a -100.0% decrease from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EV/EBITDA of Organigram Holdings Inc.
Most recent EV/EBITDAof OGI including historical data for past 10 years.Interactive Chart of EV/EBITDA of Organigram Holdings Inc.
Organigram Holdings Inc. EV/EBITDA for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | 0.0 | – | – | – | – |
2022 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
2021 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
2020 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
2019 | 0.0 | 55.94 | 32.62 | 0.0 | 55.94 |
2018 | – | – | 0.0 | 0.0 | 0.0 |
2017 | – | – | – | – | 0.0 |
2016 | – | – | – | – | 0.0 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic